Comparative Performance of 2018 LI‐RADS versus Modified LIRADS ( mLI‐RADS ): An Individual Participant Data Meta‐Analysis
Journal of Magnetic Resonance Imaging · 2024-09 · 60 (3) · 1082-1091
DOI: 10.1002/jmri.29167 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Magnetic Resonance Imaging, 2023-12. Verfasst von Stacy M Goins und 19 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR Operating Research Grant, Joan Sealy Trust for Cancer Research, Radiological Society of North America (RSNA) R&E Foundation Research Scholar Grant.
Abstract (Originalsprache)
Background
LI‐RADS version 2018 (v2018) is used for non‐invasive diagnosis of hepatocellular carcinoma (HCC). A recently proposed modification (known as mLI‐RADS) demonstrated improved sensitivity while maintaining specificity and positive predictive value (PPV) of LI‐RADS category 5 (definite HCC) for HCC. However, mLI‐RADS requires multicenter validation.
Purpose
To evaluate the performance of v2018 and mLI‐RADS for liver lesions in a large, heterogeneous, multi‐national cohort of patients at risk for HCC. Study Type Systematic review and meta‐analysis using individual participant data (IPD) [Study Protocol: https://osf.io/duys4 ]. Population 2223 observations from 1817 patients (includes all LI‐RADS categories; females = 448, males = 1361, not reported = 8) at elevated risk for developing HCC (based on LI‐RADS population criteria) from 12 retrospective studies. Field Strength/Sequence 1.5T and 3T ; complete liver MRI with gadoxetate disodium, including axial T2w images and dynamic axial fat‐suppressed T1w images precontrast and in the arterial, portal venous, transitional, and hepatobiliary phases. Diffusion‐weighted imaging was used when available. Assessment Liver observations were categorized using v2018 and mLI‐RADS. The diagnostic performance of each system's category 5 (LR‐5 and mLR‐5) for HCC were compared. Statistical Tests The Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS‐2 was applied to determine risk of bias and applicability. Diagnostic performances were assessed using the likelihood ratio test for sensitivity and specificity and the Wald test for PPV. The significance level was P < 0.05.
Results
17% (2/12) of the studies were considered low risk of bias (244 liver observations; 164 patients). When compared to v2018, mLR‐5 demonstrated higher sensitivity (61.3% vs. 46.5%, P < 0.001), similar PPV (85.3% vs. 86.3%, P = 0.89), and similar specificity (85.8% vs. 90.8%, P = 0.16) for HCC. Data Conclusion This study confirms mLR‐5 has higher sensitivity than LR‐5 for HCC identification, while maintaining similar PPV and specificity, validating the mLI‐RADS proposal in a heterogeneous, international cohort. Level of Evidence 3 Technical Efficacy Stage 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
- Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
- Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.
- Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Faculty of Medicine, The University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Stacy M Goins, Hanyu Jiang, Matthew D F McInnes, Andreu F Costa, Sang Hyun Choi, Bin Song, Ijin Joo, Andrea S Kierans, Heejin Kwon, Joanna Podgórska
Förderung
- CIHR Operating Research Grant
- Joan Sealy Trust for Cancer Research, Radiological Society of North America (RSNA) R&E Foundation Research Scholar Grant
Zitieren
APA
Goins, S. M., Jiang, H., van der Pol, C. B., Salameh, J. P., Lam, E., Adamo, R. G., McInnes, M. D. F., Costa, A. F., Clarke, C., Choi, S. H., Fraum, T. J., Ludwig, D. R., Song, B., Joo, I., Kierans, A. S., Kim, S. Y., Kwon, H., Podgórska, J., Rosiak, G., & Bashir, M. R. (2024). Comparative Performance of 2018 LI‐RADS versus Modified LIRADS ( mLI‐RADS ): An Individual Participant Data Meta‐Analysis. Journal of Magnetic Resonance Imaging, 60(3), 1082-1091. https://doi.org/10.1002/jmri.29167
Vancouver
Goins SM, Jiang H, van der Pol CB, Salameh JP, Lam E, Adamo RG, et al. Comparative Performance of 2018 LI‐RADS versus Modified LIRADS ( mLI‐RADS ): An Individual Participant Data Meta‐Analysis. Journal of Magnetic Resonance Imaging. 2024;60(3):1082-1091. doi:10.1002/jmri.29167
BibTeX
@article{Goins2024,
author = {Goins, Stacy M and Jiang, Hanyu and van der Pol, Christian B and Salameh, Jean-Paul and Lam, Eric and Adamo, Robert G and McInnes, Matthew D F and Costa, Andreu F and Clarke, Christopher and Choi, Sang Hyun and Fraum, Tyler J and Ludwig, Daniel R and Song, Bin and Joo, Ijin and Kierans, Andrea S and Kim, So Yeon and Kwon, Heejin and Podgórska, Joanna and Rosiak, Grzegorz and Bashir, Mustafa R},
title = {Comparative Performance of 2018 LI‐RADS versus Modified LIRADS ( mLI‐RADS ): An Individual Participant Data Meta‐Analysis},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
volume = {60},
number = {3},
pages = {1082--1091},
doi = {10.1002/jmri.29167}
}
EUVIMED